Hexima Share Price and Company Fundamentals



Price
$0.23
Change
0.015 (6.977%)
52 week
0.14 - 0.235

Last traded: Today at 4:34 AM

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is HXP124, which is in a phase IIb clinical trial for the treatment of fungal toenail infections. It operates in the topical antifungal sector of the pharmaceutical product development industry worldwide. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

4.34

Dividend yield

Beta

-

Market cap

$30.1M

Enterprise value

$22.58M

Company profile

Primary activitiesResearch and development of plant-derived proteins and peptides for applications as human therapeutics.
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.hexima.com.au
Mailing addressLa Trobe Institute for Molecular Science Level 4 LIMS 2 La Trobe University Melbourne VIC 3086 Australia
Phone / Fax61 3 9479 1210 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Hexima does not pay dividends.

Company Executives

As of Jul 2021, following are the company executives and directors listed on Hexima.

NameTitleAgeTotal Pay
Mr. Michael D. A. Aldridge B.Sc., M.A., B.Sc (Hons)., MApFinMD, CEO & Exec. Director53416.47k
Ms. Helen MolloyFinancial Controller & Company Sec.273.17k
Dr. Nicole van der Weerden B.Sc., Ph.D., BSc (Hons), MBA (MBS)COO & Exec. Director100.2k
Prof. Marilyn A. Anderson B.Sc., FAA, BSc (Hons), FT, FAICD, AOChief Science Officer & Exec. Director6990.99k
Dr. Neil ForresterVP of Bus. Devel.
Dr. Yolanda GasparHead of Clinical Operations
Dr. Peter J. WelburnChief Devel. Officer68
Prof. Adrienne Elizabeth ClarkeScience Advisor82

Profitability and management effectiveness

Profit margin

-164.90%

Operating margin

-161.33%

Return on assets

-35.15%

Return on equity

-128.86%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Hexima is 30.1M and its enterprise value is 22.58M. The enterprise value to revenue ratio of HXL is 8.15.

Companies similar to Hexima (HXL)

Hexima (ASX:HXL) Frequently Asked Questions

1. What is Hexima's Stock Symbol?

Hexima trades on ASX under the ticker symbol "HXL".

2. What is Hexima's stock price today?

One share of HXL stock can currently be purchased for approximately $0.23.

3. How can I contact Hexima?

Hexima's mailing address is La Trobe Institute for Molecular Science Level 4 LIMS 2 La Trobe University Melbourne VIC 3086 Australia. The company can be reached via phone at 61 3 9479 1210.

4. What is Hexima's official website?

The official website of Hexima is http://www.hexima.com.au.

5. Which share registry manages Hexima's stock?

Hexima's stock is managed by LINK MARKET SERVICES LIMITED.